Our track record in life science innovation

Our Successes

ABOUT

Vertex Ventures HC (VVHC) is part of Vertex’s global network of venture capital funds comprised of affiliates in China, Israel, Japan, Southeast Asia and India, and the US.

VVHC has built a portfolio of healthcare companies developing transformative therapies and medical technologies. It is focused on supporting its portfolio through key growth and value-creation milestones.

>25

over companies

3

FDA cleared products

$500M

under management

30

Clinical Stage Assets

Boundless Bio develops ecDNA-directed therapies (ecDTx) intended to transform the lives of patients with aggressive gene amplified cancers

Our Investments

IPO
IPO

Latest news

Vertex Ventures HC is part of the Vertex global network of venture capital funds.

In addition to the Vertex Ventures HC fund, the Vertex Global Network is comprised of affiliates in China, Israel, Japan, Southeast Asia and India, and the US. Leveraging the combined experience and resources of our extensive partner network enables our portfolio companies to realize their full potential.

© 2026 by Vertex Ventures. All rights reserved.

Legal